ethyl 2-(cyclohexylamino)propanoate | 67105-33-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: ethyl 2-(cyclohexylamino)propanoate
• 英文别名: Aethyl-N-cyclohexyl-α-aminopropionat；N-cyclohexyl-alanine ethyl ester；N-Cyclohexyl-alanin-aethylester；α-Cyclohexylamino-propionsaeure-aethylester；N-cyclohexyl-DL-alanine ethyl ester；Ethyl cyclohexylalaninate
• CAS: 67105-33-3
• 化学式: C₁₁H₂₁NO₂
• 分子量: 199.293
• InChiKey: UPPDUARXWJEKFZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 2-(cyclohexylamino)propanoate 在 三乙胺 、 三氯化磷 作用下， 以 乙醚 为溶剂， 生成 Aethyl-N-dichlorphosphino-α-aminocarboxylat
  参考文献：
  名称：

  Gololobov,Yu.G.; Nesterova,L.I., Journal of Organic Chemistry USSR (English Translation), 1978, vol. 14, p. 683 - 688

  摘要：

  DOI：
• 作为产物：
  描述：

  环己胺氢溴酸盐 、 2-溴丙酸乙酯 在 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 22.0h， 以62%的产率得到ethyl 2-(cyclohexylamino)propanoate
  参考文献：
  名称：

  Selective N-alkylation of primary amines with R–NH2·HBr and alkyl bromides using a competitive deprotonation/protonation strategy

  摘要：

  使用胺溴化物和卤代烷对初级胺进行单烷基化已成功实现。在受控反应条件下，反应物初级胺被选择性去质子化，从而可供反应，而新生成的次级胺保持质子化状态，未进一步参与烷基化反应。反应在温和的条件下进行，并适用于多种初级胺和卤代烷。

  DOI：

  10.1039/c4ra01915f

文献信息

• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：HAPLOGEN GMBH

  公开号：WO2018050631A1

  公开（公告）日：2018-03-22

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

  本发明涉及一般式（I）的新化合物，其中X和R1至R4基团的含义如描述和索赔中所述，制备这些化合物的方法以及它们作为治疗、预防或改善病毒感染的用途，以及用于治疗、预防或改善与PLA2G16相关的疾病的用途。
• PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT OR AGENT FOR PREVENTING/AMELIORATING ROUGH SKIN AND EXTERNAL COMPOSITION FOR SKIN
  申请人：Shiseido Company, Limited

  公开号：EP1884230A1

  公开（公告）日：2008-02-06

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin -inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and to further provide an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor agent, pore-shrinking agent, or rough skin preventing/amaliorating agent comprises one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof. The external composition for skin comprises the one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent.

  该发明提供了一种具有角化不全抑制、收缩毛孔或防止/改善粗糙皮肤功能的抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂，不会引起感觉刺激等安全问题，非常安全，并进一步提供了一种外用皮肤组合物，其中添加了具有上述功能的化合物。角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂包括从α-氨基酸衍生物和其盐组成的群中选择的一种、两种或更多化合物。外用皮肤组合物包括从α-氨基酸衍生物和其盐组成的群中选择的一种、两种或更多化合物，作为上述角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂。
• Parakeratosis inhibitor, pore-shrinking agent,or rough skin preventing/ameliorating agent, and external composition for skin
  申请人：Kaminuma Mikiko

  公开号：US20090215893A1

  公开（公告）日：2009-08-27

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin-inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and to further provide an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor agent, pore-shrinking agent, or rough skin preventing/amaliorating agent comprises one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof. The external composition for skin comprises the one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent.

  本发明提供了一种角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂，具有角化不全抑制、毛孔收缩或防止/减轻粗糙皮肤等功能，不会引起感觉刺激等安全问题，非常安全，进一步提供了一种添加了具有上述功能的化合物的皮肤外用组合物。该角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂包含从α-氨基酸衍生物和其盐的组中选择的一种、两种或更多化合物。该皮肤外用组合物包含从α-氨基酸衍生物和其盐的组中选择的一种、两种或更多化合物，作为上述角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂。
• Antiviral compounds
  申请人：HAPLOGEN GMBH

  公开号：US11091428B2

  公开（公告）日：2021-08-17

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

  本发明涉及通式(I)的新型化合物（其中基团X和R1至R4的含义见说明书和权利要求书）、制备这些化合物的工艺及其用于治疗、预防或改善病毒感染的用途，以及用于治疗、预防或改善与PLA2G16有关的疾病的用途。
• Kimura et al., Chemical and pharmaceutical bulletin, 1958, vol. 6, p. 159,163
  作者：Kimura et al.

  DOI：——

  日期：——